Literature DB >> 22963584

Bat rabies surveillance in Europe.

J Schatz1, A R Fooks, L McElhinney, D Horton, J Echevarria, S Vázquez-Moron, E A Kooi, T B Rasmussen, T Müller, C M Freuling.   

Abstract

Rabies is the oldest known zoonotic disease and was also the first recognized bat associated infection in humans. To date, four different lyssavirus species are the causative agents of rabies in European bats: the European Bat Lyssaviruses type 1 and 2 (EBLV-1, EBLV-2), the recently discovered putative new lyssavirus species Bokeloh Bat Lyssavirus (BBLV) and the West Caucasian Bat Virus (WCBV). Unlike in the new world, bat rabies cases in Europe are comparatively less frequent, possibly as a result of varying intensity of surveillance. Thus, the objective was to provide an assessment of the bat rabies surveillance data in Europe, taking both reported data to the WHO Rabies Bulletin Europe and published results into account. In Europe, 959 bat rabies cases were reported to the RBE in the time period 1977-2010 with the vast majority characterized as EBLV-1, frequently isolated in the Netherlands, North Germany, Denmark, Poland and also in parts of France and Spain. Most EBLV-2 isolates originated from the United Kingdom (UK) and the Netherlands, and EBLV-2 was also detected in Germany, Finland and Switzerland. Thus far, only one isolate of BBLV was found in Germany. Published passive bat rabies surveillance comprised testing of 28 of the 52 different European bat species for rabies. EBLV-1 was isolated exclusively from Serotine bats (Eptesicus serotinus and Eptesicus isabellinus), while EBLV-2 was detected in 14 Daubenton's bats (Myotis daubentonii) and 5 Pond bats (Myotis dasycneme). A virus from a single Natterer's bat (Myotis nattereri) was characterized as BBLV. During active surveillance, only oral swabs from 2 Daubenton's bats (EBLV-2) and from several Eptesicus bats (EBLV-1) yielded virus positive RNA. Virus neutralizing antibodies against lyssaviruses were detected in various European bat species from different countries, and its value and implications are discussed.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963584     DOI: 10.1111/zph.12002

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  40 in total

1.  Population genetic structure of serotine bats (Eptesicus serotinus) across Europe and implications for the potential spread of bat rabies (European bat lyssavirus EBLV-1).

Authors:  C Moussy; H Atterby; A G F Griffiths; T R Allnutt; F Mathews; G C Smith; J N Aegerter; S Bearhop; D J Hosken
Journal:  Heredity (Edinb)       Date:  2015-04-01       Impact factor: 3.821

Review 2.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Viral and Host Attributes Underlying the Origins of Zoonotic Coronaviruses in Bats.

Authors:  Alison E Stout; Qinghua Guo; Jean K Millet; Gary R Whittaker
Journal:  Comp Med       Date:  2021-10-11       Impact factor: 0.982

4.  Anti-lyssaviral activity of interferons κ and ω from the serotine bat, Eptesicus serotinus.

Authors:  Xiaocui He; Tomaš Korytař; Juliane Schatz; Conrad M Freuling; Thomas Müller; Bernd Köllner
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Serological Evidence of Lyssavirus Infection among Bats in Nagaland, a North-Eastern State in India.

Authors:  R S Mani; D P Dovih; M A Ashwini; B Chattopadhyay; P K Harsha; K M Garg; S Sudarshan; R Puttaswamaiah; U Ramakrishnan; S N Madhusudana
Journal:  Epidemiol Infect       Date:  2017-02-23       Impact factor: 4.434

6.  Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives.

Authors:  J Schatz; B Ohlendorf; P Busse; G Pelz; D Dolch; J Teubner; J A Encarnação; R-U Mühle; M Fischer; B Hoffmann; L Kwasnitschka; A Balkema-Buschmann; T C Mettenleiter; T Müller; C M Freuling
Journal:  Epidemiol Infect       Date:  2013-09-06       Impact factor: 4.434

7.  Bat rabies surveillance in Finland.

Authors:  Tiina Nokireki; Anita Huovilainen; Thomas Lilley; Eeva-Maria Kyheröinen; Christine Ek-Kommonen; Liisa Sihvonen; Miia Jakava-Viljanen
Journal:  BMC Vet Res       Date:  2013-09-08       Impact factor: 2.741

8.  Novel lyssavirus in bat, Spain.

Authors:  Nidia Aréchiga Ceballos; Sonia Vázquez Morón; José M Berciano; Olga Nicolás; Carolina Aznar López; Javier Juste; Cristina Rodríguez Nevado; Alvaro Aguilar Setién; Juan E Echevarría
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

9.  Variability in seroprevalence of rabies virus neutralizing antibodies and associated factors in a Colorado population of big brown bats (Eptesicus fuscus).

Authors:  Thomas J O'Shea; Richard A Bowen; Thomas R Stanley; Vidya Shankar; Charles E Rupprecht
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Ecology and geography of transmission of two bat-borne rabies lineages in Chile.

Authors:  Luis E Escobar; A Townsend Peterson; Myriam Favi; Verónica Yung; Daniel J Pons; Gonzalo Medina-Vogel
Journal:  PLoS Negl Trop Dis       Date:  2013-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.